Read new research studies published in the Journal and presented at the ESMO Congress.
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / October 28, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global ...
13d
CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting ...
The presentation will expand on safety, tolerability and immunogenicity results of the CVGBM trial presented last month at the European Society for Medical Oncology (ESMO) Congress, which ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback